|
(ÁÖ)»çÀ̳ؽº |
ÀǾàÇ°/ÀÇ·á±â±â ÀÓ»ó °³¹ß º»ºÎ PM
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
»ó½Ãä¿ë |
03.22 |
|
|
ºñº¸Á¸ |
ÀÓ»ó°ü¸®ÆÀ °æ·ÂÁ÷ Á÷¿ø ¸ðÁý
¼¿ï ¼ºµ¿±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
11.27 |
|
|
PPD Development Pte. Ltd. |
SCRA ¹× CRA II ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.07 |
|
|
(ÁÖ)Ƽ¾Ø¾Ë¹ÙÀÌ¿ÀÆÕ |
RA ÀÇ·á±â±â ÀÓ»ó ´ã´çÀÚ ¸ðÁý
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.29 |
|
|
(ÁÖ)½Ã¹ÍÄÚ¸®¾Æ |
(ÁÖ)½Ã¹ÍÄÚ¸®¾Æ CRA I, II, Sr. °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
11.28 |
|
|
InnoHR |
±Û·Î¹ú Á¦¾à»ç CRA 2³â ÀÌ»ó
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.18 |
|
|
½á¹Ô½áÄ¡(ÁÖ) |
¼¼°èÀû ÀÓ»ó½ÇÇè ±â°ü CRA ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.23 |
|
|
ÆĹ̼¿(ÁÖ) |
ÆĹ̼¿(ÁÖ) ÀÓ»óÆÀ °æ·ÂÁ÷ ä¿ë°ø°í
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
01.19 |
|
|
Çѱ¹¾á¼¾ |
[Janssen] Sr. Clinical Research Associate
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
05.07 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) ä¿ë_ÀÓ»ó PM,PMS PM
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
08.03 |
|
|
À£Æ®ÁÖ½Äȸ»ç |
ÀÓ»ó½ÃÇè ¸Å´ÏÀú (Clinical Research Manager)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
»ó½Ãä¿ë |
08.13 |
|
|
(ÁÖ)Á¦ÀÌÇÇÄɾîÁî |
ÀÇ·á±â±â ÀÓ»ó½ÃÇè ´ã´ç CRM/CRA/CRC ä¿ë(°æ·ÂÁ÷)
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
04.05 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - Sr CRA Opp
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
03.03 |
|
|
½ÃÁö¹ÙÀÌ¿À |
½ºÅÙÆ®TFT CRA ä¿ë °Ç
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
»ó½Ãä¿ë |
01.09 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] °æ·Â Clinical Research Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
01.28 |
|